Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …

Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with
substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the …

The aim of this study was to compare radiology-based prediction models in rheumatoid
arthritis-related interstitial lung disease (RAILD) to identify patients with a progressive fibrosis …

In this study we investigated the implication of NLRP3 inflammasomes in the pathogenesis
of idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis–usual interstitial pneumonia (…

We conducted an international study of idiopathic pulmonary fibrosis (IPF) diagnosis among
a large group of physicians and compared their diagnostic performance to a panel of IPF …

Background Pirfenidone is an antifibrotic compound approved for the treatment of idiopathic
pulmonary fibrosis (IPF). We present our real-world experience in terms of Pirfenidone’s …

The landscape of idiopathic pulmonary fibrosis (IPF) has changed. The significant progress
regarding our knowledge on the pathogenesis of the disease together with the experience …

For many years, cigarette smoking has been considered as the leading cause of chronic
obstructive pulmonary disease and lung cancer. Recently, however, it has also been associated …

For many years has been well known that smoking could cause lung damage. Chronic
obstructive pulmonary disease and lung cancer have been the two most common smoking-…

Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients
can die because of the progression of their illness, remain stable or even improve after …